These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 21911893

  • 1. Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material.
    Al-Muhannadi N, Ansari N, Brahmi U, Satir AA.
    Ann Hepatol; 2011; 10(4):508-15. PubMed ID: 21911893
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.
    Ryu HS, Lee K, Shin E, Kim SH, Jing J, Jung HY, Lee H, Jang JJ.
    Tumori; 2012; 98(4):478-84. PubMed ID: 23052165
    [Abstract] [Full Text] [Related]

  • 4. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
    Radwan NA, Ahmed NS.
    Diagn Pathol; 2012 Oct 30; 7():149. PubMed ID: 23111165
    [Abstract] [Full Text] [Related]

  • 5. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates.
    Wang L, Vuolo M, Suhrland MJ, Schlesinger K.
    Acta Cytol; 2006 Oct 30; 50(3):257-62. PubMed ID: 16780018
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma".
    Braxton DR, Saxe D, Damjanov N, Stashek K, Shroff S, Morrissette JD, Tondon R, Furth EE.
    Hum Pathol; 2017 Apr 30; 62():232-241. PubMed ID: 28232156
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
    Morrison C, Marsh W, Frankel WL.
    Mod Pathol; 2002 Dec 30; 15(12):1279-87. PubMed ID: 12481008
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Histopathology of hepatocellular carcinoma.
    Schlageter M, Terracciano LM, D'Angelo S, Sorrentino P.
    World J Gastroenterol; 2014 Nov 21; 20(43):15955-64. PubMed ID: 25473149
    [Abstract] [Full Text] [Related]

  • 19. Pathology of combined hepatocellular-cholangiocarcinoma.
    Yeh MM.
    J Gastroenterol Hepatol; 2010 Sep 21; 25(9):1485-92. PubMed ID: 20796144
    [Abstract] [Full Text] [Related]

  • 20. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel.
    Saleh HA, Aulicino M, Zaidi SY, Khan AZ, Masood S.
    Diagn Cytopathol; 2009 Mar 21; 37(3):184-90. PubMed ID: 19170172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.